Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MRK - Merck & Co Inc


Close
118.45
0.990   0.836%

Share volume: 8,874,162
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$117.46
0.99
0.84%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
48%
Profitability 23%
Dept financing 27%
Liquidity 65%
Performance 73%
Company vs Stock growth
vs
Performance
5 Days
1.59%
1 Month
2.78%
3 Months
-4.31%
6 Months
-6.46%
1 Year
10.34%
2 Year
43.98%
Key data
Stock price
$118.45
P/E Ratio 
21.84
DAY RANGE
$117.15 - $118.75
EPS 
$5.39
52 WEEK RANGE
$97.23 - $134.63
52 WEEK CHANGE
$0.11
MARKET CAP 
300.011 B
YIELD 
2.54%
SHARES OUTSTANDING 
2.533 B
DIVIDEND
$0.77
EX-DIVIDEND DATE
06/17/2024
NEXT EARNINGS DATE
10/31/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,153,280
AVERAGE 30 VOLUME 
$8,561,295
Company detail
CEO:
Region: US
Website: https://www.merck.com/
Employees: 67,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.

Recent news